Company
Brisbane, QLD
Every investor coverage indicates participated in a round Promics Limited raised.
The transaction that ended Promics Limited's run as a startup, per published coverage. It closes the funding history too, where it is the ladder's last rung.
| Bought by | Kind | Announced | Price | Sources |
|---|---|---|---|---|
| Peptech Limited | Acquisition | 2006 | - | GBS Ventures (Mon 8 Jan 2007), GBS Ventures (Mon 20 Nov 2006), GBS Ventures (Thu 18 May 2006) |
Companies Promics Limited acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Promics Limited. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Peptech announces GSK has completed its buyout of Domantis, the UK biotech in which the Australian company held a stake, yielding it 71.3 million pounds and a large gain on its original investment.
Peptech's 2006 ASX announcement, reposted by GBS Ventures, reports its takeover of Promics; the page holds only a download link, with no price or further detail in the text.
Also GBS Ventures·GBS Ventures